Gianluigi Li Bassi1, Montserrat Rigol, Joan-Daniel Marti, Lina Saucedo, Otavio T Ranzani, Ignasi Roca, Maria Cabanas, Laura Muñoz, Valeria Giunta, Nestor Luque, Mariano Rinaudo, Mariano Esperatti, Laia Fernandez-Barat, Miquel Ferrer, Jordi Vila, Jose Ramirez, Antoni Torres. 1. From the Department of Pulmonary and Critical Care Medicine, Thorax Institute, Hospital Clínic, Barcelona, Spain (G.L.B., M.R., J.-D.M., L.S., O.T.R., V.G., N.L., M.R., M.E., L.F.-B., M.F., A.T.); Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (G.L.B., M.R., J.-D.M., I.R., L.M., L.F.-B., M.F., J.V., A.T.); Centro de Investigación Biomedica En Red- Enfermedades Respiratorias (CIBERES), Mallorca, Spain (G.L.B., M.R., O.T.R., V.G., M.R., M.E., L.F.-B., M.F., A.T.); Cardiology Department, Thorax Institute, Hospital Clínic, Barcelona, Spain (M.R.); Department of Clinical Microbiology, School of Medicine, and Barcelona Centre for International Health Research, (CRESIB, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain (I.R., L.M., J.V.); Pathology Department, Hospital Clínic, Barcelona, Spain (M.C., J.R.); and University of Barcelona, Barcelona, Spain (J.V., J.R., A.T.).
Abstract
BACKGROUND: Animal models of ventilator-associated pneumonia (VAP) in primates, sheep, and pigs differ in the underlying pulmonary injury, etiology, bacterial inoculation methods, and time to onset. The most common ovine and porcine models do not reproduce the primary pathogenic mechanism of the disease, through the aspiration of oropharyngeal pathogens, or the most prevalent human etiology. Herein the authors characterize a novel porcine model of VAP due to aspiration of oropharyngeal secretions colonized by Pseudomonas aeruginosa. METHODS: Ten healthy pigs were intubated, positioned in anti-Trendelenburg, and mechanically ventilated for 72 h. Three animals did not receive bacterial challenge, whereas in seven animals, a P. aeruginosa suspension was instilled into the oropharynx. Tracheal aspirates were cultured and respiratory mechanics were recorded. On autopsy, lobar samples were obtained to corroborate VAP through microbiological and histological studies. RESULTS: In animals not challenged, diverse bacterial colonization of the airways was found and monolobar VAP rarely developed. In animals with P. aeruginosa challenge, colonization of tracheal secretion increased up to 6.39 ± 0.34 log colony-forming unit (cfu)/ml (P < 0.001). VAP was confirmed in six of seven pigs, in 78% of the cases developed in the dependent lung segments (right medium and lower lobes, P = 0.032). The static respiratory system elastance worsened to 41.5 ± 5.8 cm H2O/l (P = 0.001). CONCLUSIONS: The authors devised a VAP model caused by aspiration of oropharyngeal P. aeruginosa, a frequent causative pathogen of human VAP. The model also overcomes the practical and legislative limitations associated with the use of primates. The authors' model could be employed to study pathophysiologic mechanisms, as well as novel diagnostic/preventive strategies.
BACKGROUND: Animal models of ventilator-associated pneumonia (VAP) in primates, sheep, and pigs differ in the underlying pulmonary injury, etiology, bacterial inoculation methods, and time to onset. The most common ovine and porcine models do not reproduce the primary pathogenic mechanism of the disease, through the aspiration of oropharyngeal pathogens, or the most prevalent human etiology. Herein the authors characterize a novel porcine model of VAP due to aspiration of oropharyngeal secretions colonized by Pseudomonas aeruginosa. METHODS: Ten healthy pigs were intubated, positioned in anti-Trendelenburg, and mechanically ventilated for 72 h. Three animals did not receive bacterial challenge, whereas in seven animals, a P. aeruginosa suspension was instilled into the oropharynx. Tracheal aspirates were cultured and respiratory mechanics were recorded. On autopsy, lobar samples were obtained to corroborate VAP through microbiological and histological studies. RESULTS: In animals not challenged, diverse bacterial colonization of the airways was found and monolobar VAP rarely developed. In animals with P. aeruginosa challenge, colonization of tracheal secretion increased up to 6.39 ± 0.34 log colony-forming unit (cfu)/ml (P < 0.001). VAP was confirmed in six of seven pigs, in 78% of the cases developed in the dependent lung segments (right medium and lower lobes, P = 0.032). The static respiratory system elastance worsened to 41.5 ± 5.8 cm H2O/l (P = 0.001). CONCLUSIONS: The authors devised a VAP model caused by aspiration of oropharyngeal P. aeruginosa, a frequent causative pathogen of human VAP. The model also overcomes the practical and legislative limitations associated with the use of primates. The authors' model could be employed to study pathophysiologic mechanisms, as well as novel diagnostic/preventive strategies.
Authors: Ana Motos; Joseph L Kuti; Gianluigi Li Bassi; Antoni Torres; David P Nicolau Journal: Antimicrob Agents Chemother Date: 2019-01-29 Impact factor: 5.191
Authors: Ana Motos; Gianluigi Li Bassi; Francesco Pagliara; Laia Fernandez-Barat; Hua Yang; Eli Aguilera Xiol; Tarek Senussi; Francesco A Idone; Chiara Travierso; Chiara Chiurazzi; Rosanel Amaro; Minlan Yang; Joaquim Bobi; Montserrat Rigol; David P Nicolau; Gerard Frigola; Roberto Cabrera; Jose Ramirez; Paolo Pelosi; Francesco Blasi; Massimo Antonelli; Antonio Artigas; Jordi Vila; Marin Kollef; Antoni Torres Journal: Antimicrob Agents Chemother Date: 2021-01-20 Impact factor: 5.191
Authors: Kenny Bielen; Bart 's Jongers; Surbhi Malhotra-Kumar; Philippe G Jorens; Herman Goossens; Samir Kumar-Singh Journal: Ann Transl Med Date: 2017-03
Authors: Emanuele Rezoagli; Massimo Cressoni; Giacomo Bellani; Giacomo Grasselli; Antonio M Pesenti; Theodor Kolobow; Alberto Zanella Journal: Respir Care Date: 2019-04-23 Impact factor: 2.258
Authors: Gianluigi Li Bassi; Laia Fernandez-Barat; Lina Saucedo; Valeria Giunta; Joan Daniel Marti; Otavio Tavares Ranzani; Eli Aguilera Xiol; Montserrat Rigol; Ignasi Roca; Laura Muñoz; Nestor Luque; Mariano Esperatti; Maria Adela Saco; Jose Ramirez; Jordi Vila; Miguel Ferrer; Antoni Torres Journal: Crit Care Date: 2015-02-27 Impact factor: 9.097
Authors: Astrid de Greeff; Saskia van Selm; Herma Buys; José F Harders-Westerveen; Rahajeng N Tunjungputri; Quirijn de Mast; Andre J van der Ven; Norbert Stockhofe-Zurwieden; Marien I de Jonge; Hilde E Smith Journal: BMC Microbiol Date: 2016-06-08 Impact factor: 3.605
Authors: Gianluigi Li Bassi; Joan Daniel Marti; Eli Aguilera Xiol; Talitha Comaru; Francesca De Rosa; Montserrat Rigol; Silvia Terraneo; Mariano Rinaudo; Laia Fernandez; Miguel Ferrer; Antoni Torres Journal: Ann Intensive Care Date: 2016-07-05 Impact factor: 6.925